Min Jeong Kim
Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial.
Manuel O, Laager M, Hirzel C, Neofytos D, Walti L, Hönger G, Binet F, Schnyder A, Stampf S, Koller M, Mombelli M, Kim M, Hoffmann M, Koenig K, Hess C, Burgener A, Cippà P, Hübel K, Müller T, Sidler D, Dahdal S, Suter-Riniker F, Villard J, Zbinden A, Pantaleo G, Semmo N, Hadaya K, Enriquez N, Meylan P, Froissart M, Golshayan D, Fehr T, Huynh-Do U, Pascual M, Van Delden C, Hirsch H, Jüni P, Müller N, Swiss Transplant Cohort Study (STCS). Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial. Clin Infect Dis 2023
Sep 22, 2023Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial.
Sep 22, 2023Clin Infect Dis 2023
Manuel Oriol, Laager Mirjam, Hirzel Cédric, Neofytos Dionysios, Walti Laura N, Hönger Gideon, Binet Françoise-Isabelle, Schnyder Aurelia, Stampf Susanne, Koller Michael, Mombelli Matteo, Kim Min Jeong, Hoffmann Matthias, Koenig Katrin, Hess Christoph, Burgener Anne-Valérie, Cippà Pietro E, Hübel Kerstin, Müller Thomas F, Sidler Daniel, Dahdal Suzan, Suter-Riniker Franziska, Villard Jean, Zbinden Andrea, Pantaleo Giuseppe, Semmo Nasser, Hadaya Karine, Enriquez Natalia, Meylan Pascal R, Froissart Marc, Golshayan Délaviz, Fehr Thomas, Huynh-Do Uyen, Pascual Manuel, Van Delden Christian, Hirsch Hans H., Jüni Peter, Müller Nicolas J., Swiss Transplant Cohort Study (STCS)
Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased.
Diebold M, Locher E, Boide P, Enzler-Tschudy A, Faivre A, Fischer I, Helmchen B, Hopfer H, Kim M, Moll S, Nanchen G, Rotman S, Saganas C, Seeger H, Kistler A. Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased. Kidney Int 2022; 102:1409-1419.
Sep 10, 2022Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased.
Sep 10, 2022Kidney Int 2022; 102:1409-1419
Diebold Matthias, Locher Eleonore, Boide Philipp, Enzler-Tschudy Annette, Faivre Anna, Fischer Ingeborg, Helmchen Birgit, Hopfer Helmut, Kim Min Jeong, Moll Solange, Nanchen Giliane, Rotman Samuel, Saganas Charalampos, Seeger Harald, Kistler Andreas D
Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort study.
Jäger C, Stampf S, Molyneux K, Barratt J, Golshayan D, Hadaya K, Huynh-Do U, Binet F, Mueller T, Koller M, Kim M. Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort study. BMC Nephrol 2022; 23:178.
May 10, 2022Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort study.
May 10, 2022BMC Nephrol 2022; 23:178
Jäger Cédric, Stampf Susanne, Molyneux Karen, Barratt Jonathan, Golshayan Déla, Hadaya Karine, Huynh-Do Uyen, Binet Françoise-Isabelle, Mueller Thomas F, Koller Michael, Kim Min Jeong
Vitamin-D-Intoxikation als seltene Ursache einer schweren Hyperkalzämie
Beglinger C, Kim M, Tsinalis D, Enzler-Tschudy A, Jung K, Brändle M, Binet F. Vitamin-D-Intoxikation als seltene Ursache einer schweren Hyperkalzämie - Wenn YouTube alles besser weiss …. Swiss Med Forum 2018; 18:796-799.
Nov 1, 2018Vitamin-D-Intoxikation als seltene Ursache einer schweren Hyperkalzämie
Nov 1, 2018Swiss Med Forum 2018; 18:796-799
Beglinger Catherine, Kim Min Jeong, Tsinalis Dimitrios, Enzler-Tschudy Annette, Jung Karin, Brändle Michael, Binet Françoise-Isabelle
ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial
Kim M, Tsinalis D, Franz S, Binet F, Gürke L, Mihatsch M, Steiger J, Thiel G, Dickenmann M. ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial. Annals of transplantation : quarterly of the Polish Transplantation Society 2008; 13:21-7.
Jan 1, 2008ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial
Jan 1, 2008Annals of transplantation : quarterly of the Polish Transplantation Society 2008; 13:21-7
Kim Min Jeong, Tsinalis Dimitrios, Franz Stefan, Binet Françoise-Isabelle, Gürke Lorenz, Mihatsch Michael J, Steiger Jürg, Thiel Gilbert, Dickenmann Michael